logo
Plus   Neg
Share
Email

Stock Alert: BioNTech Up 65%; To Co-Develop Coronavirus Vaccine With Pfizer

Shares of BioNTech SE (BNTX) are currently gaining over 65% on Tuesday morning after the company announced that it will team up with pharma giant Pfizer Inc. (PFE) to develop a potential vaccine for coronavirus Covid-19.

The companies will jointly develop BioNTech's mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection. The companies have singed a letter of intent regarding the co-development and distribution, excluding China.

The latest collaboration builds on a 2018 agreement between the two companies to develop mRNA-based vaccines for prevention of influenza.

The companies will start working together immediately. Pfizer and BioNTech will use research and development sites from both companies, including in the US and Germany.

Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development & Medical, Pfizer, said, "We believe that by pairing Pfizer's development, regulatory and commercial capabilities with BioNTech's mRNA vaccine technology and expertise as one of the industry leaders, we are reinforcing our commitment to do everything we can to combat this escalating pandemic, as quickly as possible."

The coronavirus pandemic has so far infected nearly 179,000 people globally and killed more than 7,000.

BNTX is currently trading at $65.96, up $25.96 or 64.89%, on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT